Open Access. Powered by Scholars. Published by Universities.®
Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Adverse effects (1)
- Bioanalytical method (1)
- Carbamazepine (1)
- Co-prescribing (1)
- Co-prescription rate (1)
-
- Epilepsy (1)
- Evidence-based practice (1)
- Finasteride (1)
- Intervention (1)
- Mental disorders (1)
- Naloxone (1)
- Narcan (1)
- Nurse (1)
- Nursing (1)
- Opioid (1)
- Physician (1)
- Post-finasteride syndrome (1)
- Practitioner (1)
- Primary care (1)
- Provider education (1)
- Sexual dysfunctions (1)
- Therapeutic drug monitoring (1)
- Validation (1)
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Analytical, Diagnostic and Therapeutic Techniques and Equipment
A Multi-Faceted Intervention To Improve Naloxone Co-Prescription Rates Among Primary Care Providers, Jolane S. Conklin
A Multi-Faceted Intervention To Improve Naloxone Co-Prescription Rates Among Primary Care Providers, Jolane S. Conklin
Evidence-Based Practice Project Reports
It is estimated that 91 Americans die every day due to opioid overdoses, with at least half of those overdoses involving an opioid prescription (CDC, 2016d). To address this issue, the U.S. Department of Health and Human Services (USDHHS) has initiated an opioid initiative, and the Centers for Disease Control and Prevention (CDC) has released a clinical guideline, both of which include a focus on increasing use of naloxone. Despite these recommendations, providers often fail to co-prescribe naloxone to patients at increased risk of opioid overdose. The purpose of this evidence-based practice (EBP) project was to evaluate the effect of …
Therapeutic Drug Monitoring And Methods Of Quantitation For Carbamazepine, Cristian Tuchila, Daniela Luiza Baconi, Cristina Dinu Pirvu, Denisa O. Balalau, Ana Maria Vlasceanu, Miriana Stan, Cristian Balalau
Therapeutic Drug Monitoring And Methods Of Quantitation For Carbamazepine, Cristian Tuchila, Daniela Luiza Baconi, Cristina Dinu Pirvu, Denisa O. Balalau, Ana Maria Vlasceanu, Miriana Stan, Cristian Balalau
Journal of Mind and Medical Sciences
Carbamazepine is an early anticonvulsant still used today in the treatment of several forms of epilepsy. An active metabolite in the human body contributes to its pharmacological effect. Carbamazepine metabolism has high inter-individual variability, such that it is relatively difficult to establish a direct link between dose and concentration, or between concentration and pharmacological effect. Carbamazepine is thus a good candidate for therapeutic drug monitoring (TDM). Good UV specific absorbance and high plasmatic concentrations allow for the use of UV detection, which is often more accessible than other methods of detection. This paper presents several methods used for the detection …
The Postfinasteride Syndrome; An Overview, David L. Rowland, Ion G. Motofei, Florian Popa, Vlad D. Constantin, Adriana Vasilache, Ioana Păunică, Cristian Bălălău, Georgeta P. Păunică, Petrisor Banu, Stana Păunică
The Postfinasteride Syndrome; An Overview, David L. Rowland, Ion G. Motofei, Florian Popa, Vlad D. Constantin, Adriana Vasilache, Ioana Păunică, Cristian Bălălău, Georgeta P. Păunică, Petrisor Banu, Stana Păunică
Journal of Mind and Medical Sciences
As a 5-α reductase inhibitor, Finasteride has proven effective in ameliorating two conditions documented to be androgen dependent, namely male androgenic alopecia and benign prostatic hyperplasia. Therapeutic results are maintained as long as the drug is administered, with treatment cessation generally leading to the return of symptomatology for each condition. In addition, during the therapeutic phase, several adverse effects have been reported, some of which persist long or indefinitely after treatment cessation, known as “post-finasteride syndrome.”
Herein we present and discuss the most common finasteride side effects, along with a psycho-neuroendocrine rationale that could explain the persistence of many adverse …